Skip to main content
. 2022 Apr 26;6(4):469–481. doi: 10.1007/s41669-022-00330-w

Table 2.

Newcastle–Ottawa Scale quality assessment

Quality rating study counts
Good Fair Poor
SCD vs. non-SCD (n = 5) 3 0 2
SCD burden
 General (n = 8) 3 1 4
 Complications (n = 11) 5 0 6
SCD burden of treatment (n = 12) 6 0 6
SCD burden of transfusion complications (n = 4) 4 0 0

SCD sickle cell disease